Market News
ACADIA Pharmaceuticals (ACAD): Q4 2019 Earnings Snapshot
— ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) reported Q4 2019 loss of $0.34 per share, vs. $0.36 expected. — Revenue grew 65% to $98.3 million vs.…